Loading organizations...
Esco Lifesciences is a Singapore-based manufacturer of laboratory equipment, biopharmaceutical manufacturing tools, and in vitro fertilization medical devices. The organization operates eight manufacturing and research hubs globally, maintaining direct offices in over twenty countries and a sales network spanning more than one hundred nations. Supported by a workforce of over 1,300 employees, the enterprise has achieved a compound annual growth rate exceeding twenty percent over a ten-year period. In May 2021, the company closed a $200 million Series A funding round led by prominent investors including Vivo Capital, Novo Holdings, China Investment Corporation, and EDBI. The group also operates a corporate venture capital arm called Esco Ventures and recently expanded its bioprocessing capabilities through the acquisition of Esco Bioengineering. Esco Lifesciences was founded in 1978 by the Lin family and is currently led by XQ Lin and XL Lin.
Esco Lifesciences has raised $200.0M across 1 funding round.
Esco Lifesciences has raised $200.0M in total across 1 funding round.
Esco Lifesciences has raised $200.0M across 1 funding round. Most recently, it raised $200.0M Series A in May 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 27, 2021 | $200M Series A | Kasim Kutay, Shan FU | China Investment Corporation, EDBI | Announced |
Esco Lifesciences has raised $200.0M in total across 1 funding round.
Esco Lifesciences's investors include Kasim Kutay, Shan Fu, China Investment Corporation, EDBI.
